RE: FDA omicron impact of testing4 Dec 2021 13:16
The company , by their own admission got it wrong with the PCR test concentrating on the US market along with BC and looking for the big profit margin , we have a very good product , get the pricing right and distribution and it will sell in all markets , get that wrong and we will have a nother PCR disaster, lets hope the company learnt their lesson.